Proteins threading

Fig. 4. Schematic of the protein threading problem, where I L represent particular core segments and (-) corresponds to variable loop segments ...

TF Smith, L Lo Conte, J Bienkowska, C Gaitatzes, RGJ Rogers, R Lathrop. CuiTent limitations to protein threading approaches. J Comput Biol 4 217-225, 1997. 

RH Lathrop, TE Smith. Global optimum protein threading with gapped alignment and empirical pair score functions. I Mol Biol 255 641-665, 1996. 

Lathrop, R. FI. (1994). The protein threading problem with sequence amino acid interaction preferences is NP-complete. Protein Eng. 7, 1059—1068. 

Wendler P, Shorter J, Snead D, Plisson C, Clare DK, Lindquist S, Saibil HR (2009) Motor mechanism for protein threading through Hspl04. Mol Cell 34 81-92... 

Xu, Y. 2003. RAPTOR Optimal protein threading by linear programming, the inaugural issue. J. Bioinform. Comput. Biol. 1, 95-117. 

Yu, C.-N., Joachims, T., Elber, R. Training protein threading models using structural SVMs, in ICML Workshop on Learning in Structured Output Spaces, 2006. 

Xu, Y., Xu, D. Protein threading using PROSPECT Design and evaluation. Proteins Struct., Funct., Genet. 2000,40,343-54. 

When blood is lost or clotting is initiated in some other way, a complex cascade of biochemical reactions is set in motion, which ends in the formation of a network or clot of insoluble protein threads enmeshing the blood cells. These threads are produced by the polymerisation of the molecules of fibrinogen (a soluble protein present in the plasma) into threads of insoluble fibrin. The penultimate step in the chain of reactions requires the presence of an enzyme, thrombin, which is produced from its precursor prothrombin, already present in the plasma. This is initiated by factor lit (tissue thromboplastin), and subsequently involves various factors including activated factor Vn, DC, X, XI and XII, and is inhibited by antithrombin in. Platelets are also involved in the coagulation process. Fibrinolysis is the mechanism of dissolution of fibrin clots, which can be promoted with thrombolytics. For further information on platelet aggregation and clot dissolution, see Antiplatelet drugs and thrombolytics , (p.697). 

---